|
| |
Image Results
Loading...
Loading...
Glioblastoma 2009 Pages on BioPortfolio:
|
BioPortfolio - Glioblastoma - InDepth
14 Nov 2009 ... Medical News Today: Nov 11 2009 12:58PM Matching: glioblastoma ... Therapeutics Daily: Nov 11 2009 5:09AM Matching: glioblastoma ...
http://www.bioportfolio.com/indepth/Glioblastoma.pdf...
|
BioPortfolio - GLI1 - glioma-associated oncogene homolog 1 (zinc ...
Hedgehog signaling is aberrantly activated in glioma, medulloblastoma,... 29th October, 2009, M & M Medical Bioinformatics, Hongo 113-0033, Japan. ...
http://www.bioportfolio.com/gene/2735-GLI1.html...
|
BioPortfolio - Glioma - InDepth
6 Nov 2009 ... Oncogene Journal: Nov 13 2009 1:11AM Matching: glioma ... Doctors Guide: Nov 11 2009 3:21AM Matching: glioma ...
http://www.bioportfolio.com/indepth/Glioma.pdf...
|
Brain cancer: glioblastoma incidence to pass 18000 cases by 2015
Wednesday November 18 2009 | Biotechnology feed | All feeds ... The incidence of glioblastoma is increasing, with the 2003 level of 17604 cases predicted to ...
http://www.bioportfolio.com/news/datamonitor_137.htm...
|
BioPortfolio News: NexGenix Pharmaceuticals Holdings, Inc ...
23 Oct 2009 ... Thursday 22nd of October 2009 12:58 ... pilot study demonstrating increased survival of GL261 Glioma Bearing Mice at the upcoming 2009 Joint ...
http://www.bioportfolio.com/news/NexGenix-Pharmaceuticals-Aw...
|
BioPortfolio - Carolina Neurosurgery & Spine Associates - Profile
Glioblastoma multiforme (GBM) accounts for the majority of primary...12th November, 2009. Brain Tumor Center of Excellence, Department of Neurosurgery,
...
http://www.bioportfolio.com/biocorporate/21109-Carolina%2525...
|
BioPortfolio - Carolina Neurosurgery & Spine Associates - Profile
8 Oct 2009 ... Conventional therapies for glioblastoma multiforme (GBM) fail to target...15th October, 2009. Division of Neurosurgery, Department of ...
http://www.bioportfolio.com/biocorporate/21109-Carolina%2BNe...
| Results from other life science and pharmaceutical sites:
Immunotherapy Approach Tested in Glioblastoma
January 15, 2009 — A new immunotherapy approach to the treatment of glioblastoma has shown promise in animal studies and is due to be tested in patients ...
http://www.medscape.com/viewarticle/586852...
|
Genentech: Newsroom: Press Releases: News Release May 5, 2009
5 May 2009 ... Tuesday, May 5, 2009. FDA Grants Accelerated Approval of Avastin for Brain Cancer (Glioblastoma) That Has Progressed Following Prior Therapy ...
http://www.gene.com/gene/news/press-releases/display.do?meth...
|
MSH6 mutations arise in glioblastomas during temozolomide therapy ...
2009 Jul 15;15(14):4622-9. Epub 2009 Jul 7. MSH6 mutations arise in glioblastomas during temozolomide therapy and mediate temozolomide resistance.
...
http://www.ncbi.nlm.nih.gov/pubmed/19584161...
|
Genentech: Newsroom: Press Releases: News Release March 31, 2009
31 Mar 2009 ... Silver Spring, Md. -- March 31, 2009 -- Genentech, ... Glioblastoma affects approximately 10000 people per year in the United States. ...
http://www.gene.com/gene/news/press-releases/display.do?meth...
|
Glioma - Wikipedia, the free encyclopedia
Sun JY, Yang H, Miao S, Li JP, Wang SW, Zhu MZ, Xie YH, Wang JB, Liu Z, Yang Q ( May 2009). "Suppressive effects of swainsonine on C6 glioma cell in vitro ...
http://en.wikipedia.org/wiki/Glioma...
|
Glioblastoma Response to VEGF-Inhibitor Therapy
30 Apr 2009 ... AACR 2009: MRI Measure Predicts Glioblastoma Response to VEGF-Inhibitor Therapy. Zosia Chustecka. Authors and Disclosures ...
http://www.medscape.com/viewarticle/702147...
|
Glioblastoma multiforme - Wikipedia, the free encyclopedia
Glioblastoma multiforme (GBM) is the most common and most aggressive type of primary brain ..... This page was last modified on 26 November 2009 at 05:22.
...
http://en.wikipedia.org/wiki/Glioblastoma_multiforme...
|
(("glioblastoma"[TIAB] NOT Medline[SB]) OR "glioblastoma"[MeSH ...
Phase II trial of vorinostat in recurrent glioblastoma multiforme: a north ... 2009 Apr 20;27(12):2052-8. Epub 2009 Mar 23. Erratum in: J Clin Oncol. ...
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Detai...
|
Genentech: Newsroom: Press Statements
9 Mar 2009 ... The FDA is expected to make a decision on the application by May 5, 2009. Glioblastoma is the most aggressive form of brain cancer, ...
http://www.gene.com/gene/news/press-releases/press_statement...
|
Glioblastoma multiforme: the terminator. [Proc Natl Acad Sci U S A ...
2009]. ReviewA role for the NG2 proteoglycan in glioma progression. Stallcup WB, Huang FJ. Cell Adh Migr. 2008 Jul; 2(3):192-201. Epub 2008 Jul 13. ...
http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&uid=10841...
|
|
